FDA approves Adlyxin to treat type 2 diabetes

You are subscribed to FDA Press Releases for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

 

07/28/2016 07:53 AM EDT

The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.

.


This email was sent to bsamad2007.adnan@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332) Powered by GovDelivery

Comments

Popular Posts

We have Your e-Wallet ready. Claim in 3hrs

Commissions Successfully

Your order requires immediate confirmation.

Engr Suman wants to be friends on Facebook

You’re four weeks away from more followers 📱

Reduced Payment!.

Beneficiary countersignature modification

Fwd: Claim "Climate law & governance" for your profile